About: Immunomonitoring after idiotype protein-KLH vaccination in patiens with multiple myeloma relapse     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
Description
  • Malignant cells in multiple myeloma (MM) produce a monoclonal immunoglobulin which is tumor-specific and can be used for the induction of specific T cells. The idiotype (Id) is expresse dat the cell surfaře of malignant plasma cells and allow the recognition and targeting of these cells by Id-specific T lymphocytes. A phase II clinical study has started in our center, investigating the efficacy and toxicity of Id conjugated with keyhole limpet hemocyanin (KLH) given as a vaccine to patiens with MM. The aim of this therapy was to induce specific immune response directed against the tumor cells. Twelve patiens with stable disease or with slow progression not requiring systemic therapy were immunized six times with or without interleukin-2.
  • Malignant cells in multiple myeloma (MM) produce a monoclonal immunoglobulin which is tumor-specific and can be used for the induction of specific T cells. The idiotype (Id) is expresse dat the cell surfaře of malignant plasma cells and allow the recognition and targeting of these cells by Id-specific T lymphocytes. A phase II clinical study has started in our center, investigating the efficacy and toxicity of Id conjugated with keyhole limpet hemocyanin (KLH) given as a vaccine to patiens with MM. The aim of this therapy was to induce specific immune response directed against the tumor cells. Twelve patiens with stable disease or with slow progression not requiring systemic therapy were immunized six times with or without interleukin-2. (en)
  • Buňky mnohočetného myelomu produkují nádorově specifický monoklonální imunoglobulin, který lze použít pro indukci specifických T buněk. Idiotyp (Id) je exprimován na povrchu maligních buněk a může napomoci rozpoznání a cílení těchto buněk Id-specifickými T lymfocyty. V našem centru byla zahájena klická studie II. fáze, která sleduje účinnost a cytotoxicitu konjugátu Id-keyhole limpet hemocyanin (KLH) podávaného jako vakcína u myelomových pacientů. Cílem této terapie je navození specifické imunitní odpovědi cílené proti nádorovým buňkám. 12 pacientů se stabilním onemocněním příp. pomalou progesí, která nevyžadovala systematickou terapii, bylo 6x vakcinováno s nebo bez podpory interleukinu 2. (cs)
Title
  • Immunomonitoring after idiotype protein-KLH vaccination in patiens with multiple myeloma relapse
  • Immunomonitoring after idiotype protein-KLH vaccination in patiens with multiple myeloma relapse (en)
  • Imunonitoring pacientů s mnohočetným myelomem po vakcinaci idiotypovým proteinem konjugovaným s KLH (cs)
skos:prefLabel
  • Immunomonitoring after idiotype protein-KLH vaccination in patiens with multiple myeloma relapse
  • Immunomonitoring after idiotype protein-KLH vaccination in patiens with multiple myeloma relapse (en)
  • Imunonitoring pacientů s mnohočetným myelomem po vakcinaci idiotypovým proteinem konjugovaným s KLH (cs)
skos:notation
  • RIV/65269705:_____/05:#0000009!RIV06-MZ0-65269705
http://linked.open.../vavai/riv/strany
  • 185-186
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • P(NC7475)
http://linked.open...iv/cisloPeriodika
  • S1
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 524271
http://linked.open...ai/riv/idVysledku
  • RIV/65269705:_____/05:#0000009
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • immunomonitoring; idiotype protein-KLH; vaccination; multiple myeloma,relaps (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...odStatuVydavatele
  • IT - Italská republika
http://linked.open...ontrolniKodProRIV
  • [8A6855DB5F6B]
http://linked.open...i/riv/nazevZdroje
  • Haematologica/the hematology journal
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...cetTvurcuVysledku
http://linked.open...vavai/riv/projekt
http://linked.open...UplatneniVysledku
http://linked.open...v/svazekPeriodika
  • 90
http://linked.open...iv/tvurceVysledku
  • Adam, Zdeněk
  • Hájek, Roman
  • Krejčí, Marta
  • Penka, Miroslav
  • Vorlíček, Jiří
  • Buchler, Tomáš
  • Kovářová, Lucie
  • Očadlíková, Darina
  • Smejkalová, Jana
issn
  • 0390-6078
number of pages
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 67 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software